Basel
Switzerland
113
2026-04-02
The entities that hold a legal rights for patent applications filed by inventor Jaeschke Georg:
Georg Jaeschke from Basel, CH has applied for patents for these inventions. The list has both pending applications and granted patents:
NOVEL COMPOUNDS
#2 | 2026-02-12ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR
#3 | 2026-01-15NOVEL COMPOUNDS
#4 | 2026-01-08COMBINATION OF ALLOSTERIC AND ORTHOSTERIC EGFR INHIBITORS FOR THE TREATMENT OF CANCER
#5 | 2025-11-20NOVEL COMPOUNDS
#6 | 2025-10-09NEW INDAZOLE DERIVATIVES
#7 | 2025-09-18EGFR INHIBITOR FOR THE TREATMENT OF CANCER
#8 | 2025-09-04COMPOUNDS
#9 | 2025-08-28ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR
#10 | 2025-06-19NOVEL COMPOUNDS
#11 | 2024-12-12HETEROCYCLIC NLRP3 INHIBITORS
#12 | 2024-09-19PYRIDAZINE DERIVATIVES AS INHIBITORS OF NLRP3
#13 | 2024-08-22FUSED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS NLRP3 INHIBITORS
#14 | 2024-06-27NOVEL COMPOUNDS
#15 | 2024-05-16EGFR Degraders to Treat Cancer Metastasis to the Brain or CNS
#16 | 2024-04-25NOVEL COMPOUNDS
#17 | 2024-03-07ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR
#18 | 2024-02-22NEW INDAZOLE DERIVATIVES
#19 | 2024-01-18NEW INDAZOLE DERIVATIVES
#20 | 2024-01-04NEW INDAZOLE ACETYLENE DERIVATIVES
#21 | 2023-04-13Isoindolinone and indazole compounds for the degradation of EGFR
#22 | 2023-02-23EGFR INHIBITORS
#23 | 2023-02-23EGFR INHIBITORS FOR THE TREATMENT OF CANCER
#24 | 2023-02-02EGFR INHIBITORS
#25 | 2022-10-06EGFR INHIBITORS FOR THE TREATMENT OF CANCER
#26 | 2022-10-06EGFR INHIBITOR FOR THE TREATMENT OF CANCER
#27 | 2022-10-06NEW EGFR INHIBITORS
#28 | 2022-10-06NEW EGFR INHIBITORS
#29 | 2022-06-02Arylsulfonamide derivatives
#30 | 2022-05-05THERAPEUTIC EGFR INHIBITORS
#31 | 2022-04-28Ethynyl derivatives
#32 | 2022-04-14EGFR INHIBITOR FOR MEDICAL USE
#33 | 2021-09-30Ethynyl derivatives
#34 | 2021-09-02Ethynyl derivatives
#35 | 2021-03-18Isoindolinone derivatives as selective allosteric inhibitors of Egfr mutant cancers
#36 | 2021-03-112-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds
#37 | 2020-11-19BIFUNCTIONAL MOLECULES THAT DEGRADE EGFR
#38 | 2020-10-01BIFUNCTIONAL INHIBITORS WITH EGFR HAVING A E3 UBIQUITIN LIGASE MOIETY
#39 | 2020-09-17BRIDGED PIPERIDINE DERIVATIVES
#40 | 2020-09-17Substituted imidazo[1,2-a]imidazoles as modulators of metabotropic glutamate receptor 4 activity
#41 | 2020-08-13Ethynyl derivatives
#42 | 2020-04-02Substituted isoindole allosteric EGFR inhibitors
#43 | 2019-10-102-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds
#44 | 2019-05-16ETHYNYL DERIVATIVES
#45 | 2019-04-25Ethynyl derivatives
#46 | 2019-01-10Bridged piperidine derivatives
#47 | 2018-05-17Ethynyl derivatives
#48 | 2018-05-10Ethynyl derivatives
#49 | 2018-03-29Ethynyl derivatives
#50 | 2018-01-04Ethynyl derivatives
#51 | 2017-08-03Ethynyl derivatives
#52 | 2017-04-27Ethynyl derivatives
#53 | 2017-01-12Ethynyl derivatives
#54 | 2016-12-15Ethynyl derivatives
#55 | 2016-07-21ETHYNYL DERIVATIVES
#56 | 2016-05-12Ethynyl derivatives
#57 | 2016-02-11Arylethynyl derivatives
#58 | 2015-08-13Ethynyl derivatives
#59 | 2015-08-13Ethynyl derivatives
#60 | 2015-08-13Ethynyl derivatives
#61 | 2015-07-16Arylethynyl derivatives
#62 | 2015-06-11Arylethynyl pyrimidines
#63 | 2015-05-14Arylethynyl derivatives
#64 | 2015-04-30Ethynyl compounds
#65 | 2014-11-27Dual Modulators Of 5HT2A and D3 Receptors
#66 | 2014-06-05Arlethynyl derivatives
#67 | 2014-03-13Ethynyl compounds useful for treatment of CNS disorder
#68 | 2013-10-17Arylethynyl derivatives
#69 | 2013-07-11Arylethynyl derivatives
#70 | 2013-06-27Dual modulators of 5HTand Dreceptors
#71 | 2013-05-23Positive allosteric modulators (PAM)
#72 | 2013-05-16PHARMACEUTICALLY ACCEPTABLE MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND THEIR METHODS OF IDENTIFICATION
#73 | 2013-04-11Ethynyl derivatives
#74 | 2013-04-11Ethynyl derivatives
#75 | 2012-11-01Ethynyl nitrogen containing heteroaryl pyrazolidin-3-one derivatives
#76 | 2012-11-01Ethynyl compounds
#77 | 2012-10-25Phenyl or pyridinyl-ethynyl derivatives
#78 | 2012-02-16DUAL MODULATORS OF 5HT2A AND D3 RECEPTORS
#79 | 2012-01-05Benzoyl-piperidine derivatives as dual modulators of the 5-HTand Dreceptors
#80 | 2011-10-13Arylethynyl derivatives
#81 | 2011-06-23Ethynyl compounds useful for treatment of CNS disorders
#82 | 2011-04-28Positive allosteric modulators (PAM)
#83 | 2011-01-20Imidazoles
#84 | 2010-09-09PYRIDINE-2-YL CARBOXYLIC ACID AMIDES
#85 | 2010-03-25Benzo[D]isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine D3 receptors
#86 | 2010-03-25Dand 5-HTreceptor modulators
#87 | 2010-03-25Isoxazolo[4,5]pyridin-3-yl-piperazin derivatives useful as modulators of dopamine D3 receptors
#88 | 2010-03-25PYRIDINYLPIPERAZIN DERIVATIVES USEFUL AS MODULATORS OF DOPAMINE D3 RECEPTORS
#89 | 2010-02-25Diazole derivatives
#90 | 2009-09-17Pyrazine-2-carboxyamide derivatives
#91 | 2009-02-26METHODS FOR THE TREATMENT OF GERD WITH MGLUR5 ANTAGONISTS
#92 | 2009-02-12Benzoyl-piperidine derivatives as dual modulators of the 5-HT2A and D3 receptors
#93 | 2009-01-29DUAL MODULATORS OF 5HT2A AND D3 RECEPTORS
#94 | 2009-01-15Imidazole derivatives
#95 | 2008-10-30PYRIDINE-2-CARBOXYAMIDE DERIVATIVES
#96 | 2008-05-22Imidazole derivatives
#97 | 2008-05-01Imidazole derivatives
#98 | 2008-05-01Ether derivatives
#99 | 2008-02-19Imidazole derivatives
#100 | 2007-08-234-aryl-pyridine-2-carboxyamide derivatives
187858 ⎘